Description
SUSTANCIA: DIABECARE GRISI JABON CORPORAL CAJA C/BARRA C/125 G
AFINITOR® 10 mg es un medicamento oncológico de Novartis que contiene everolimus como principio activo
KADCYLA® 100 mg es un medicamento de uso intravenoso que contiene Trastuzumab Emtansina (T-DM1)
Presentación en frasco salero con 10 g Contiene 10 g de sulfatiazol Dosis: Consulte a su médico Vía de Administración: Tópico
METROSON TAB. 250 MG. CAJA C/20 FENOTRINA SUSTANCIA: DIABECARE GRISI JABON CORPORAL
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
